We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+8.94%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$76.2B
AUM Growth
+$2.6B
(+3.5%)
Cap. Flow
-$2.97B
Cap. Flow
% of AUM
-3.9%
Top 10 Holdings %
Top 10 Hldgs %
21.61%
Holding
3,238
New
235
Increased
684
Reduced
2,065
Closed
243
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$77.3M |
| 2 |
Blackstone
BX
|
+$53.2M |
| 3 |
NXP Semiconductors
NXPI
|
+$40.8M |
| 4 |
Palantir
PLTR
|
+$34.3M |
| 5 |
Snowflake
SNOW
|
+$24.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$206M |
| 2 |
Microsoft
MSFT
|
+$163M |
| 3 |
Linde
LIN
|
+$133M |
| 4 |
Amazon
AMZN
|
+$94.7M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$82.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.34% |
| 2 | Financials | 14.16% |
| 3 | Healthcare | 12.95% |
| 4 | Consumer Discretionary | 12.06% |
| 5 | Communication Services | 9.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2226
C3.ai
AI
$1.59B
| $1.05M | ﹤0.01% |
16,738
+2,210
| +15% | +$137K |
|
2227
CNA Financial
CNA
$14.1B
| $1.05M | ﹤0.01% |
23,026
-2,687
| -10% | -$126K |
|
2228
MBIA
MBI
$260M
| $1.04M | ﹤0.01% |
94,986
-11,606
| -11% | -$116K |
|
2229
Vuzix
VUZI
$224M
| $1.04M | ﹤0.01% |
+56,969
| New | +$1.15M |
|
2230
Inseego
INSG
$90.5M
| $1.04M | ﹤0.01% |
10,343
+2,674
| +35% | +$244K |
|
|
DM
2231
DELISTED
Desktop Metal, Inc.
DM
| $1.04M | ﹤0.01% |
+9,059
| New | +$1.19M |
|
|
ALTA
2232
DELISTED
Altabancorp
ALTA
| $1.04M | ﹤0.01% |
24,036
-1,408
| -6% | -$61.5K |
|
2233
Ranpak Holdings
PACK
$473M
| $1.04M | ﹤0.01% |
41,564
+3,922
| +10% | +$82.3K |
|
2234
Lands' End
LE
$403M
| $1.04M | ﹤0.01% |
25,311
-167
| -0.7% | -$4.56K |
|
|
DSPG
2235
DELISTED
DSP Group Inc
DSPG
| $1.04M | ﹤0.01% |
70,033
+8,334
| +14% | +$124K |
|
2236
Camden National
CAC
$976M
| $1.03M | ﹤0.01% |
21,611
-2,796
| -11% | -$133K |
|
2237
BioLife Solutions
BLFS
$1.7B
| $1.02M | ﹤0.01% |
23,027
+9,055
| +65% | +$319K |
|
2238
Vaxcyte
PCVX
$8.64B
| $1.02M | ﹤0.01% |
45,346
+16,763
| +59% | +$343K |
|
2239
QCR Holdings
QCRH
$1.7B
| $1.02M | ﹤0.01% |
21,234
-2,103
| -9% | -$101K |
|
2240
Ezcorp Inc
EZPW
$1.71B
| $1.02M | ﹤0.01% |
168,466
-7,552
| -4% | -$47.7K |
|
2241
Douglas Dynamics
PLOW
$1.02B
| $1.01M | ﹤0.01% |
24,906
-2,828
| -10% | -$124K |
|
|
AMTI
2242
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
| $1.01M | ﹤0.01% |
22,131
-1,556
| -7% | -$73.6K |
|
|
DFTX
2243
Definium Therapeutics
DFTX
$6.12B
| $1.01M | ﹤0.01% |
+19,488
| New | +$1.02M |
|
|
GTHX
2244
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $1.01M | ﹤0.01% |
45,982
-3,496
| -7% | -$77.7K |
|
2245
Quince Therapeutics
QNCX
$29.5M
| $1M | ﹤0.01% |
95
+4
| +4% | +$33.5K |
|
|
QUOT
2246
DELISTED
Quotient Technology Inc
QUOT
| $1M | ﹤0.01% |
92,926
-24,761
| -21% | -$331K |
|
2247
Advantage Solutions
ADV
$361M
| $1M | ﹤0.01% |
+3,719
| New | +$1.15M |
|
2248
TFS Financial
TFSL
$4.93B
| $1M | ﹤0.01% |
49,359
-1,504
| -3% | -$31.3K |
|
2249
Citi Trends
CTRN
$605M
| $1M | ﹤0.01% |
11,494
-5,822
| -34% | -$536K |
|
2250
Gorman-Rupp
GRC
$2.21B
| $997K | ﹤0.01% |
28,947
+421
| +1% | +$14.6K |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2021 Portfolio in Review
As of Q2 2021, RhumbLine Advisers held 3,238 positions worth $76.2B, up 3.5% from $73.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
RhumbLine Advisers withdrew a net $2.97B in Q2 2021, closing 243 positions and reducing 2,065 holdings. Its most notable exit was Varian Medical Systems, Inc., an estimated $32.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
Against the trend, RhumbLine Advisers opened a new position in DraftKings worth $14.2M.
- RhumbLine Advisers's largest Q2 2021 buy was DraftKings: 271,227 shares worth $14.2M.
- RhumbLine Advisers added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $77.3M increase.
- RhumbLine Advisers's biggest Q2 2021 reduction was Apple, cutting an estimated $206M.
- RhumbLine Advisers fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $32.1M.
- RhumbLine Advisers's ten largest holdings make up 22% of its $76.2B portfolio in Q2 2021.
- RhumbLine Advisers opened 235 new positions and closed 243 in Q2 2021.
- RhumbLine Advisers's portfolio value rose 3.5% quarter-over-quarter to $76.2B.
Based on RhumbLine Advisers's 13F filing for Q2 2021, filed 5 Aug 2021.